Xibenolol
| Code | Size | Price |
|---|
| TAR-T35176-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Xibenolol is a biochmeical.
CAS:
30187-90-7
Formula:
C15H25NO2
Molecular Weight:
251.37
Purity:
0.98
SMILES:
Cc1cccc(OCC(O)CNC(C)(C)C)c1C
References
Honma S, Ito T, Kambegawa A. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man. Chem Pharm Bull (Tokyo). 1985 Feb;33(2):760-8. PubMed PMID: 2861914.
Ishimori T, Shiratsuchi K, Izumi A, Himori N. [Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats]. Nihon Yakurigaku Zasshi. 1982 Dec;80(6):463-9. Japanese. PubMed PMID: 6131020.
Honma S, Ito T, Matsuki Y. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro]. Yakugaku Zasshi. 1986 May;106(5):406-13. Japanese. PubMed PMID: 2876088.
Himori N, Honma S, Izumi A, Ishimori T. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs. Naunyn Schmiedebergs Arch Pharmacol. 1981 Feb;316(1):19-23. PubMed PMID: 6116195.